Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 1, 2024
- Accession no.
- 0001415889-24-011870
- Filed
- May 1, 2024
- Trade date
- Apr 29-30, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 11 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.71M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2024 | Common Stock | MOption exerciseAcquired | +3,600 | $129.49 | +$466,164 | 3,730 | Direct | |
| Apr 29, 2024 | Common Stock | SSaleDisposed | −35 | $234.76 | −$8,216.6 | 3,695 | Direct | |
| Apr 29, 2024 | Common Stock | SSaleDisposed | −278 | $236.84F2 | −$65,841.52 | 3,417 | Direct | |
| Apr 29, 2024 | Common Stock | SSaleDisposed | −596 | $237.70F3 | −$141,669.2 | 2,821 | Direct | |
| Apr 29, 2024 | Common Stock | SSaleDisposed | −1,706 | $238.56F4 | −$406,983.36 | 1,115 | Direct | |
| Apr 29, 2024 | Common Stock | SSaleDisposed | −732 | $239.78F5 | −$175,518.96 | 383 | Direct | |
| Apr 29, 2024 | Common Stock | SSaleDisposed | −253 | $240.55F6 | −$60,859.15 | 130 | Direct | |
| Apr 30, 2024 | Common Stock | MOption exerciseAcquired | +3,600 | $129.49 | +$466,164 | 3,730 | Direct | |
| Apr 30, 2024 | Common Stock | SSaleDisposed | −1,000 | $234.71F7 | −$234,710 | 2,730 | Direct | |
| Apr 30, 2024 | Common Stock | SSaleDisposed | −2,349 | $235.52F8 | −$553,236.48 | 381 | Direct | |
| Apr 30, 2024 | Common Stock | SSaleDisposed | −251 | $236.37F9 | −$59,328.87 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2024 | Common Stock | MOption exerciseDisposed | −3,600 | $0.00 | $0 | 291,869 | Direct | |
| Apr 30, 2024 | Common Stock | MOption exerciseDisposed | −3,600 | $0.00 | $0 | 288,269 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $236.065 to $237.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $237.135 to $238.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $238.15 to $239.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $239.28 to $240.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $240.28 to $240.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $234.04 to $235.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $235.045 to $236.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $236.115 to $236.605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.